Hoth Therapeutics Net Income

Hoth Therapeutics (HOTH) currently reports a net income of $-13M as of June 2026. That compares with $-8.1M in the prior-year period — down 65.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Hoth Therapeutics's net income history and peer comparisons.

Hoth Therapeutics's net income decreased from $-8.1M to $-13M — a 65.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hoth Therapeutics's net income of $-13M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Hoth Therapeutics reported $-13M in net income as of June 2026. That compares with $-8.1M in the prior-year period — down 65.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-13M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Hoth Therapeutics, and consider following HOTH for alerts when major investors trade the stock.